Jane Armitage
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Diabetes Treatment and Management 6
- Surgery top 1%
- Lipoproteins and Cardiovascular Health 44
-
- Blood Pressure and Hypertension Studies 9
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 7
- Nutrition and Dietetics top 1%
-
- Health Systems, Economic Evaluations, Quality of Life 19
- Pharmaceutical Economics and Policy 8
- Co-authors
- Sarah LewingtonRory CollinsWilliam G. HerringtonBen LaceyPaul SherlikerSarah ParishRobert ClarkePeter Sleight
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Jane Armitage
89 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Endocrinology, Diabetes and Metabolism 1.2k
- Surgery 2.6k
- Cardiology and Cardiovascular Medicine 1.2k
- Cancer Research 621
- Nutrition and Dietetics 576
Countries citing papers authored by Jane Armitage
This map shows the geographic impact of Jane Armitage's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Armitage with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Armitage more than expected).
Fields of papers citing papers by Jane Armitage
This network shows the impact of papers produced by Jane Armitage. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Armitage. The network helps show where Jane Armitage may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jane Armitage, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 35 | |
| 3 | 2021 | 114 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 11 | |
| 6 | 2020 | 26 | |
| 7 | LENS - a clinical trial embedded in routine clinical practice to reduce the burden of diabetic eye disease | 2017 | 2 |
| 8 | 2017 | 48 | |
| 9 | 2017 | 0 | |
| 10 | 2016 | 0 | |
| 11 | 2016 | 51 | |
| 12 | 2015 | 69 | |
| 13 | 2015 | 12 | |
| 14 | 2012 | 78 | |
| 15 | 2011 | 125 | |
| 16 | Low Use of Statins among High-risk Patients in China | 2010 | 1 |
| 17 | 2008 | 11 | |
| 18 | 2007 | 83 | |
| 19 | The safety of statins in clinical practicebreakdown → | 2007 | 613 |
| 20 | 2006 | 74 |
About Jane Armitage
Jane Armitage is a scholar working on Family Practice, Endocrinology, Diabetes and Metabolism and Surgery, having authored 92 papers that have together received 5.7k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (44 papers), Health Systems, Economic Evaluations, Quality of Life (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Blood Pressure and Hypertension Studies (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Pharmaceutical Economics and Policy (8 papers), Cancer, Lipids, and Metabolism (7 papers) and Diabetes Treatment and Management (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.2k citations), Surgery (2.6k citations) and Cardiology and Cardiovascular Medicine (1.2k citations). Jane Armitage has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Sarah Lewington, Rory Collins, William G. Herrington, Ben Lacey, Paul Sherliker, Sarah Parish, Robert Clarke, Peter Sleight, Richard Peto and Louise Bowman. Their work appears in journals such as Trials, European Heart Journal, The Lancet, Current Opinion in Lipidology and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.